Siga Technologies Inc financial data

Symbol
SIGA on Nasdaq
Industry
Pharmaceutical Preparations
Location
31 East 62 Nd Street, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Former names
SIGA PHARMACEUTICALS INC (to 5/25/2000)
Latest financial report
10-K - Q4 2024 - Mar 11, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 567 % +0.34%
Quick Ratio 161 % -11.6%
Debt-to-equity 22 % -1.92%
Return On Equity 33 % -26.4%
Return On Assets 27.1 % -26.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 71.4M shares
Common Stock, Shares, Outstanding 71.4M shares +0.44%
Entity Public Float 351M USD +52%
Common Stock, Value, Issued 7.14K USD +0.44%
Weighted Average Number of Shares Outstanding, Basic 71.3M shares -0.15%
Weighted Average Number of Shares Outstanding, Diluted 71.9M shares +0.32%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 139M USD -0.86%
Research and Development Expense 12.3M USD -25.1%
Costs and Expenses 68.7M USD +22.1%
Operating Income (Loss) 70M USD -16.3%
Nonoperating Income (Expense) 6.09M USD -64.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 76.1M USD -13.3%
Income Tax Expense (Benefit) 16.9M USD -14.5%
Net Income (Loss) Attributable to Parent 59.2M USD -13%
Earnings Per Share, Basic 0.83 USD/shares -12.6%
Earnings Per Share, Diluted 0.82 USD/shares -13.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 155M USD +3.5%
Accounts Receivable, after Allowance for Credit Loss, Current 21.2M USD +0.17%
Inventory, Net 49.6M USD -22.8%
Assets, Current 231M USD -3.33%
Deferred Income Tax Assets, Net 10.9M USD -1.75%
Property, Plant and Equipment, Net 1.3M USD -2.5%
Goodwill 898K USD 0%
Other Assets, Noncurrent 241K USD -88.4%
Assets 244M USD -3.94%
Accounts Payable, Current 1.34M USD -7.96%
Accrued Liabilities, Current 5.64M USD -44.6%
Contract with Customer, Liability, Current 10.3M USD -50.3%
Liabilities, Current 25.3M USD -53.2%
Operating Lease, Liability, Noncurrent 800K USD
Liabilities 28.5M USD -50.4%
Retained Earnings (Accumulated Deficit) -22.8M USD +41.4%
Stockholders' Equity Attributable to Parent 216M USD +9.62%
Liabilities and Equity 244M USD -3.94%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.12M USD -125%
Net Cash Provided by (Used in) Financing Activities -159K USD +97.9%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 600M shares 0%
Common Stock, Shares, Issued 71.4M shares +0.44%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 155M USD +3.5%
Deferred Tax Assets, Valuation Allowance 921K USD -2.38%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 12.3M USD -1.59%
Operating Lease, Liability 1.36M USD
Lessee, Operating Lease, Liability, to be Paid 1.48M USD -7.91%
Property, Plant and Equipment, Gross 7.36M USD +6.43%
Operating Lease, Liability, Current 547K USD -3.05%
Lessee, Operating Lease, Liability, to be Paid, Year Two 686K USD +10.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 626K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +110%
Deferred Income Tax Expense (Benefit) 36.5K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 115K USD +1.62%
Lessee, Operating Lease, Liability, to be Paid, Year Three 166K USD -59.2%
Deferred Tax Assets, Operating Loss Carryforwards 1.17M USD -2.38%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 4.69M USD -7.66%
Lessee, Operating Lease, Liability, to be Paid, Year Four 410K USD 0%
Operating Lease, Payments 700K USD 0%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 138K USD +5.61%
Deferred Tax Assets, Net of Valuation Allowance 11.4M USD -1.53%